| Andrew E Anyadiegwu, MD | |
|
203 Walls Dr, Suite 208, Cleburne, TX 76033-7022 | |
| (817) 641-0808 | |
| Not Available |
| Full Name | Andrew E Anyadiegwu |
|---|---|
| Gender | Male |
| Speciality | Pulmonary Disease |
| Experience | 33 Years |
| Location | 203 Walls Dr, Cleburne, Texas |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1437181542 | NPI | - | NPPES |
| 101434984 | Medicaid | PA |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207RC0200X | Internal Medicine - Critical Care Medicine | MD 426941 (Pennsylvania) | Secondary |
| 207RP1001X | Internal Medicine - Pulmonary Disease | MD426941 (Pennsylvania) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Texas Health Harris Methodist Hospital Cleburne | Cleburne, TX | Hospital |
| Texas Health Huguley Hospital Fort Worth South | Burleson, TX | Hospital |
| Texas Health Harris Methodist Hospital Fort Worth | Fort worth, TX | Hospital |
| Baylor Scott & White All Saints Medical Center Fort Worth | Fort worth, TX | Hospital |
| Baylor University Medical Center | Dallas, TX | Hospital |
| Entity Name | North Texas Pulmonary Assoc. |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1245427061 PECOS PAC ID: 3476643461 Enrollment ID: O20071213000825 |
News Archive
DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced NTT DATA, its strategic partner in Japan, has signed its first Enterprise Transfer client.
A new DNA vaccine when delivered to the skin prompts an immune response that produces antibodies to protect against toxic proteins associated with Alzheimer's disease – without triggering severe brain swelling that earlier antibody treatments caused in some patients.
The current treatment standard recommended for most women with early stage breast cancer is breast conservation therapy, consisting of lumpectomy following by radiotherapy. The purpose of the radiotherapy is to kill any tumor cells in the remaining breast area that may have been missed by the surgery.
Researchers have identified a protein in the brain that halts the progression of Alzheimer's disease in human brain tissue. The protein, known as "transthyretin," protects brain cells from gradual deterioration by blocking another toxic protein that contributes to the disease process.
Intermittent androgen deprivation is as effective as continuous therapy for men with rising prostate-specific antigen levels after primary or salvage radiotherapy, say researchers who believe the break from treatment improves quality of life.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Andrew E Anyadiegwu, MD 203 Walls Dr, Suite 208, Cleburne, TX 76033-7022 Ph: (817) 641-0808 | Andrew E Anyadiegwu, MD 203 Walls Dr, Suite 208, Cleburne, TX 76033-7022 Ph: (817) 641-0808 |
News Archive
DATATRAK International, Inc., a technology and services company focused on global eClinical solutions for the clinical trials industry, today announced NTT DATA, its strategic partner in Japan, has signed its first Enterprise Transfer client.
A new DNA vaccine when delivered to the skin prompts an immune response that produces antibodies to protect against toxic proteins associated with Alzheimer's disease – without triggering severe brain swelling that earlier antibody treatments caused in some patients.
The current treatment standard recommended for most women with early stage breast cancer is breast conservation therapy, consisting of lumpectomy following by radiotherapy. The purpose of the radiotherapy is to kill any tumor cells in the remaining breast area that may have been missed by the surgery.
Researchers have identified a protein in the brain that halts the progression of Alzheimer's disease in human brain tissue. The protein, known as "transthyretin," protects brain cells from gradual deterioration by blocking another toxic protein that contributes to the disease process.
Intermittent androgen deprivation is as effective as continuous therapy for men with rising prostate-specific antigen levels after primary or salvage radiotherapy, say researchers who believe the break from treatment improves quality of life.
› Verified 4 days ago
Dr. Shoaib Khalil, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1900 E Henderson St, Cleburne, TX 76031 Phone: 817-645-2322 Fax: 817-645-2360 | |
Dr. John Bamidele Daramola, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 505 N Ridgeway Dr, Suite 282, Cleburne, TX 76033 Phone: 817-556-0201 Fax: 817-556-0213 | |
Dr. Elena Gurova, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 519 N Main St, Cleburne, TX 76033 Phone: 817-645-5915 Fax: 817-645-5935 | |
Hanmanth Rao Bejjanki, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 203 Walls Dr Ste 209, Cleburne, TX 76033 Phone: 817-648-0123 Fax: 888-253-6968 | |
Dr. Siavosh Vafadari, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 1301 W Henderson St, Cleburne, TX 76033 Phone: 817-558-3937 Fax: 817-422-0862 | |
Dr. Albert Sean Dalley, MD Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 808 N Nolan River Rd, Cleburne, TX 76033 Phone: 817-558-3937 Fax: 817-641-6424 | |
Dr. Sandhya Bejjanki, M.D. Pulmonary Disease Medicare: Accepting Medicare Assignments Practice Location: 191 Walls Dr, Cleburne, TX 76033 Phone: 817-648-0120 Fax: 817-648-0121 |